Ionpath Receives Strategic Investment to Support Spatial Proteomics Innovation
May 11, 2022
New funding will be used to advance Ionpath’s MIBI technology in translational research and precision medicine MENLO PARK, Calif. — Ionpath, Inc., a leader in high-definition spatial proteomics, today announced that Thermo Fisher Scientific, the world leader in serving science, has made a strategic investment in the company. Details of the investment are not being [...]
QIAGEN proposes expansion of Supervisory Board
May 11, 2022
Dr. Eva Pisa proposed as a new member to the Supervisory Board, contributes significant leadership experience in Life Science and Molecular Diagnostics industry All seven current Supervisory Board members to stand for re-election for one-year terms Annual General Meeting to be held on June 23, 2022, in Venlo, the Netherlands VENLO, the Netherlands -- QIAGEN [...]
QIAGEN acquires majority stake in enzymes provider BLIRT S.A.
May 11, 2022
BLIRT adds new R&D and manufacturing capabilities for customized and standardized recombinant enzymes, as well as molecular biology reagents Strengthens QIAGEN’s sample technologies business, one of the company’s five pillars of growth, also with additional global production capacities and broader commercial reach 96% majority stake acquired in BLIRT S.A. through the transaction with a group [...]
Appleton Woods & Flow Robotics announce distribution collaboration
May 11, 2022
Appleton Woods will represent Flow Robotics’ user-friendly pipetting robot, flowbot® ONE, in the UK market. COPENHAGEN, DENMARK -- UK supplier of lab equipment, consumables, and reagents, Appleton Woods Ltd, and Danish robot developer, Flow Robotics A/S, has ventured into a distribution- and service collaboration to deliver cost-effective liquid handling automation that all labs can use. “This [...]
Curiox Biosystems Establishes a Scientific Advisory Board
May 11, 2022
WOBURN, Mass. -- Curiox Biosystems, Inc., a global leader in biological sample preparation for life science research, has formed a Scientific Advisory Board (SAB) to accelerate the company's rapid expansion. The SAB includes experts in microengineering and microfluidics as well as noteworthy scientists in the fields of oncology and diagnostic flow cytometry. It will provide [...]
May 11, 2022
PARSIPPANY, NJ -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, has announced that in association with Miroculus, Inc., a developer of revolutionary tools for personal lab automation, it will optimize next generation sequencing (NGS) library preparation utilizing its digital microfluidics (DMF) technology. Also working in conjunction with [...]
GenNext Technologies Introduces Protein Footprinting Products to Japan through Kiko Tech Co., LTD
May 11, 2022
Caption: The Flash Oxidation (Fox™) System for HRPF analysis. HALF MOON BAY, Calif. – Life Science Newswire – GenNext Technologies, Inc. (GenNext), announced today a partnership with Kiko Tech Co., Ltd., to provide Flash Oxidation (Fox™) Protein Footprinting Systems to the Japanese life science research market. Under an agreement between the parties, Kiko Tech has been [...]
bit.bio’s new Huntington’s Disease human cell model, for in vitro research and drug discovery
May 11, 2022
CAMBRIDGE, UK – bit.bio’s new ioGlutamatergic Neurons HTT50CAG/WT provide a human, cell-based, in vitro model of Huntington’s Disease (HD) that accurately reflects the disease genotype. Offering industry-leading consistency and scalability, this first product from the new ioDisease Model portfolio has been developed to support key applications within drug discovery including target identification and high-throughput screening. The life sciences industry is challenged [...]
May 10, 2022
ROCKVILLE, MD, USA -- AOAC INTERNATIONAL (AOAC) recently announced it has partnered with Signature Science, LLC (SigSci) as its test material provider for AOAC’s new Cannabis/Hemp Proficiency Testing (PT) Program. In launching this program, AOAC will become the only PT provider offering actual >0.3% THC cannabis flower/plant, as well as hemp, as a matrix. AOAC’s PT programs [...]
May 10, 2022
Collaboration will accelerate plasmid optimization and sourcing services for new and existing viral vector and mRNA-based vaccine and therapeutic customers RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, and Cytovance Biologics, Inc., a biologics contract development and [...]

